About Certara
Certara is a company based in Princeton (United States) founded in 2008 was acquired by EQT in July 2017.. The company has 1,550 employees as of December 31, 2024. Certara has completed 10 acquisitions, including Analytica Laser, Applied BioMath and BaseCase. Certara offers products and services including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™. Certara operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Inpharmatica and CytoReason, among others.
- Headquarter Princeton, United States
- Employees 1550 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Certara, Inc.
-
Annual Revenue
$385.15 M8.7as on Dec 31, 2024
-
Net Profit
$-12.05 M78.23as on Dec 31, 2024
-
EBITDA
$86.85 M23.85as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Golub Capital
& 5 more
-
Employee Count
1550
as on Dec 31, 2024
-
Investments & Acquisitions
Analytica Laser
& 9 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Certara
Certara is a publicly listed company on the NASDAQ with ticker symbol CERT in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Certara
Certara offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for PK, PD, and toxicokinetic analysis and modeling
Platform for data standardization and validation in drug development
System for predicting drug behavior in diverse populations
Solution for publishing and transmitting eCTD submissions
Unlock access to complete
Unlock access to complete
Funding Insights of Certara
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(19 Dec 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - Certara | Valuation |
investors |
|
| Jul, 2021 | Amount | Post-IPO - Certara | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Certara | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Certara
Certara has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Golub Capital, EQT and Mubadala. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments target specialty industrials and healthcare sectors.
|
Founded Year | Domain | Location | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Founded Year | Domain | Location | |
|
The U.S. Food and Drug Administration is tasked with regulating food, drugs, and medical products.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Certara
Certara has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Analytica Laser, Applied BioMath and BaseCase. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Deep learning platform is provided for life sciences market research.
|
2016 | ||||
|
Systems biology and pharmacology modeling services to aid drug discovery and development
|
2013 | ||||
|
Clinical pharmacology consulting services are provided for drug development.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Certara
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Certara Comparisons
Competitors of Certara
Certara operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Inpharmatica and CytoReason, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Certara
Frequently Asked Questions about Certara
When was Certara founded?
Certara was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Where is Certara located?
Certara is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Who is the current CEO of Certara?
William Feehery is the current CEO of Certara.
How many employees does Certara have?
As of Dec 31, 2024, the latest employee count at Certara is 1,550.
What is the annual revenue of Certara?
Annual revenue of Certara is $385.15M as on Dec 31, 2024.
What does Certara do?
Certara was founded in 2008 and is headquartered in Princeton, United States. Operations focus on the biosimulation sector, where software solutions for molecular modeling, pharmacokinetic and pharmacodynamic simulations, clinical trial modeling, and scientific informatics are developed. Drug development consulting and medical writing services are also delivered to support pharmaceutical research and regulatory needs.
Who are the top competitors of Certara?
Certara's top competitors include Insitro, HotSpot Therapeutics and GRO Biosciences.
What products or services does Certara offer?
Certara offers Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™.
Is Certara publicly traded?
Yes, Certara is publicly traded on NASDAQ under the ticker symbol CERT.
How many acquisitions has Certara made?
Certara has made 10 acquisitions, including Analytica Laser, Applied BioMath, and BaseCase.
Who are Certara's investors?
Certara has 6 investors. Key investors include Golub Capital, EQT, Mubadala, Arsenal Capital Partners, and European Union.
What is Certara's ticker symbol?
The ticker symbol of Certara is CERT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.